Affordable GLP-1 weight loss medication starting at $199/mo. Licensed providers, free shipping.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Weight Loss Medication Cost is already seeing results
Weight Loss Medication Cost: Weight Method offers compounded GLP-1 treatment starting at $199/month. Compounded semaglutide from $199/month and tirzepatide from $329/month, prescribed by licensed providers. Includes virtual medical consultation and free direct shipping.
Key Fact
Weight Method's compounded GLP-1 programs are $154/month for compounded semaglutide and $329/month for compounded tirzepatide, all-inclusive, with no insurance required. FDA-approved GLP-1 brands sit at the premium end of the prescription market when purchased cash-pay. Compounded medications are not FDA-approved.
Source: Weight Method pricing, February 2026
Weight management medication options in 2025 cover a wide spectrum. Generic phentermine is inexpensive and FDA-approved for short-term use (12 weeks). Orlistat (Alli/Xenical) is mid-range and carries significant GI side effects. Contrave (bupropion/naltrexone) is mid-range. At the premium end, FDA-approved GLP-1 medications include brand-name Wegovy® (semaglutide) and brand-name Zepbound® (tirzepatide). These brands are priced by their manufacturers at the top of the prescription market. Published clinical-trial outcomes describe the FDA-approved brand-name products, which the FDA reviewed for safety, efficacy, and manufacturing quality. Weight Method's compounded GLP-1 programs sit outside this comparison: compounded medications are not FDA-approved; the FDA has not reviewed them. Compounded semaglutide is offered at $154/month and compounded tirzepatide at $329/month, all-inclusive. The clinical-trial outcomes for the FDA-approved brand-name products do not describe the compounded versions; your prescribing provider can discuss what to expect from compounded therapy based on your individual clinical profile.
Patients comparing weight management medication costs face several tradeoffs beyond the headline price. FDA-approved options include the FDA review process — designed to evaluate safety, efficacy, and manufacturing quality. Compounded options do not undergo that review. For patients considering any weight management medication, the conventional pathway costs include the medication itself plus concurrent care for blood pressure, diabetes management, cholesterol, and other weight-related healthcare. Sustained weight reduction has been associated with reduced spending in those concurrent areas in observational studies, though individual outcomes vary widely. Weight Method's compounded GLP-1 programs are structured as flat all-inclusive monthly fees ($154/month for compounded semaglutide, $329/month for compounded tirzepatide) with no deductible, copay tier, or annual reset. The decision between an FDA-approved brand-name medication and a compounded alternative is not solely financial; factors include FDA review status, prior medication response, individual clinical profile, and access timing. Your prescribing provider can help you weigh these factors.
Answer a few quick questions to see if you qualify for GLP-1 medication.
Check EligibilityCompounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
We offer the most affordable GLP-1 treatments. Starting at $199/month.
See PricingFree consultation. No commitment.